Clinical and Translational Medicine (Nov 2021)

Identification of TMB, CD8 T‐cell abundance, and homologous repair pathway mutation frequency as predictors of the benefit–toxicity ratio of anti‐PD‐1/PD‐L1 therapy

  • Junyu Long,
  • Xu Yang,
  • Jin Bian,
  • Dongxu Wang,
  • Anqiang Wang,
  • Yu Lin,
  • Mingjun Zheng,
  • Haohai Zhang,
  • Xinting Sang,
  • Haitao Zhao

DOI
https://doi.org/10.1002/ctm2.598
Journal volume & issue
Vol. 11, no. 11
pp. n/a – n/a

Abstract

Read online

No abstracts available.